Platinum-Based Chemotherapy With/Without INCMGA00012, an Anti-PD-1 Antibody, in Non-Small Cell Lung Cancer
Status:
Recruiting
Trial end date:
2024-08-31
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess the efficacy and safety of platinum-based chemotherapy
with or without INCMGA00012 in participants with metastatic squamous and nonsquamous
non-small cell lung cancer (NSCLC).